SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Chinese Drugmaker Ganzhou Hemay Delays Hong Kong Listing

Ganzhou Hemay delayed its Hong Kong listing, citing market conditions.

Related stories